期刊文献+

维生素D_3对大鼠血清铁和肝脏铁调素基因表达的影响 被引量:1

Effect of vitamin D_3 on the expression of hepatic hepcidin mRNA and serum iron in rats
下载PDF
导出
摘要 目的探讨维生素D3对大鼠体内铁代谢的影响。方法雌性SD大鼠12只,随机分成2组:实验组和对照组。实验组给予肌肉注射维生素D3 3×105 U/Kg,每周一次,持续4周;对照组按相同方法给予肌肉注射生理盐水。用全自动生化分析仪测大鼠血清钙、铁水平,用一步法逆转录聚合酶链反应方法测定肝脏铁调素(hepcidin)的mRNA水平。结果对照组大鼠血清钙、铁水平分别为2.48±0.03mmol/L和58.06±4.14umol/L;实验组大鼠血清钙、铁水平分别为3.01±0.12mmol/L和51.02±5.31umol/L;与对照组相比,实验组大鼠血清钙显著升高(P<0.01),血清铁显著降低(P<0.05),肝脏铁调素mRNA水平无显著变化。结论维生素D3可能通过增加肠道对钙的吸收降低了血清铁。 Objective To investigate the influence of vitamin D3 on the iron metabolism in rats in vivo. Methods Twelve female SD rats were divided into 2 groups: the experimental group and the control group. The rats in the experimental group were given vitamin D3 3×10^5 U/Kg by intramuscular administration once a week for 4 weeks. The rats in the control group were given normal saline by intramuscular administration. Automatic biochemical analyzer was used to measure serum iron and calcium levels. The expression of hepcidin mRNA in the liver were detected with one-step reverse transcription - polymerase chain reaction (RT-PCR). Results The levels of serum calcium and iron were 2.48±0.03mmol/L and 58.06±4. 14umol/L, respectively in rats of control group, and 3. 01±0. 12mmol/L and 51.02±5.31umol/L, respectively in rats of experimental group. Serum calcium increased (P 〈0. 01 ) and serum iron (P 〈0.05) decreased in rats of experimental group significantly than those in control group. Expression of hepcidin mRNA in the liver did not change significantly. Conclusion Vitamin D3 may decrease serum iron level by increasing intestinal calcium absorption.
出处 《中国骨质疏松杂志》 CAS CSCD 2011年第7期620-623,共4页 Chinese Journal of Osteoporosis
基金 江苏省自然基金题(BK2008165) 教育部博士学科点专项科研基金(20103201110020)
关键词 维生素D3 铁调素 铁代谢 Vitamin D3 Hepcidin Iron metabolism
  • 相关文献

参考文献12

  • 1Guggenbuhl P, Deugnier Y, Boisdet JF, et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int, 2005, 16 ( 12 ) : 1809-1814.
  • 2Tsay J, Yang Z, Ross FP, et al. Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood, 2010, 116(14) :2582-2589.
  • 3Weinberg ED. Iron loading: a risk factor for osteoporosis. Biometals, 2006, 19 (6) :633-635.
  • 4Weinberg ED. Role of iron in osteoporosis. Pediatr Endocrinol Rev, 2008, 6 Suppl 1:81-85.
  • 5Liu G, Men P, Kenner GH, et al. Age-associated iron accumulation in bone : implications for postmenopausal osteoporosis and a new target for prevention and treatment bychelation. Biometals, 2006, 19(3) :245-251.
  • 6Jian J, Pelle E, Huang X. Iron and menopause: does increased iron affect the health of postmenopausal women? Antioxid Redox Signal, 2009, 11 (12) :2939-2943.
  • 7Youjia Xu, Pierre Sirois, Kai Li. Iron overload plays a unique role in osteoporosis. Blood (E-letter) 9 September 2010.
  • 8Nakayama H. Active vitamin D3 therapy for gulucocorticoid- induced osteoporosis. Clin Calcium, 2006, 16(7) : 1201-1207.
  • 9Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Throrab Vase Bid, 2000, 20(2) :317-327.
  • 10Masuhara T, Migicovsky BB. Vitamin D and the intestinal absorption of iron and cobalt. J Nutr, 1963, 80:332-336.

同被引文献6

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部